Idexx Laboratories (IDXX) Non-Current Debt (2009 - 2026)

Idexx Laboratories' Non-Current Debt history runs 18 years deep, the most recent figure standing at $299.9 million for Q1 2026.

• In Q1 2026, Non-Current Debt fell 33.34% year-over-year to $299.9 million; the TTM figure through Mar 2026 stood at $299.9 million (down 33.34% YoY), while the FY2025 annual figure was $374.8 million, down 16.66% from the prior year.
• Non-Current Debt for Q1 2026 stood at $299.9 million, down from $374.8 million in the prior quarter.
• The five-year high for Non-Current Debt was $773.4 million in Q1 2022, with the low at $299.9 million in Q1 2026.
• The 5-year median for Non-Current Debt is $618.8 million (2023), against an average of $570.6 million.
• The sharpest annual moves came in 2022 and 2026: Non-Current Debt declined 0.69% in 2022, then sank 33.34% in 2026.
• Idexx Laboratories' Non-Current Debt stood at $694.4 million in 2022, then retreated by 10.3% to $622.9 million in 2023, then decreased by 27.79% to $449.8 million in 2024, then slipped by 16.66% to $374.8 million in 2025, then fell by 20.01% to $299.9 million in 2026.
• Business Quant data shows IDXX's Non-Current Debt at $299.9 million in Q1 2026, $374.8 million in Q4 2025, and $374.8 million in Q3 2025.